Sharps Technology is a company that makes special syringes. They announced they will sell one million syringes to a customer, so their stock price went up a lot. This made other stocks go up too.

summary:
Sharps Technology announced a big sale of their special syringes, which made their stock price go up. This also helped some other stocks go up. Read from source...

As an AI model, I have the ability to process large amounts of data and provide valuable insights. I can analyze the article you provided and generate comprehensive investment recommendations and risks for the stocks mentioned in the article. Here are my suggestions:

1. Sharps Technology Shares (STSS): Buy, as the company received two purchase orders for a total of approximately one million SecureGard syringes for 2024 delivery. This indicates strong demand for the company's products and a potential for growth in the future. The stock price is currently at $0.3030, which is 31.7% lower than the previous closing price. This presents an opportunity for investors to buy at a discounted price and potentially profit from the stock's rebound.

2. Qualigen Therapeutics, Inc. (QLGN): Sell, as the stock price has risen 53% in pre-market trading, which indicates a high level of speculation and volatility. The company is a clinical-stage biopharmaceutical company developing novel therapeutics for cancer and other diseases. While the company has shown promise, there is still a high level of risk and uncertainty associated with its clinical trials and regulatory approvals.

3. Maxeon Solar Technologies, Ltd. (MAXN): Hold, as the stock price has risen 18.7% in pre-market trading after being granted a U.S. Patent for "Protection Coating For Solar Cell Wafers". The company is a leading solar cell and module manufacturer, with a focus on high-efficiency solar cell technology. The patent is a positive development for the company, but there are still challenges in the solar industry, such as competition and regulatory hurdles.

4. MediWound Ltd. (MDWD): Sell, as the stock price has risen 17.2% in pre-market trading after dipping around 7% on Wednesday. The company is a biopharmaceutical company developing and commercializing novel therapeutics and medical devices for the treatment of severe medical needs. The stock price has been highly volatile in recent weeks, making it a risky investment.

5. Foresight Autonomous Holdings Ltd. (FRSX): Hold, as the stock price has risen 16.9% in pre-market trading. The company is an innovator of automotive stereo vision and artificial intelligence for robotic vehicles. The company has partnerships with major automotive manufacturers and technology companies, but it still faces challenges in the highly competitive